Measuring eye pressure and fluid outflow during cataract or glaucoma surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-arm observational study will use a sterile, single-use Deltran I pressure sensor to record intraoperative intraocular pressure and calculate outflow capacity in adults undergoing cataract and/or glaucoma surgery at the New York Eye and Ear Infirmary of Mount Sinai. Investigators will collect intraoperative tonographic biometry and follow postoperative intraocular pressure and clinical outcomes for up to 90 days. The goal is to correlate intraoperative pressure and outflow measurements with short-term surgical success and complications. Participants are recruited from surgeons affiliated with the Mount Sinai Health System and will receive standard surgical care with added intraoperative monitoring.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals undergoing cataract and/or glaucoma surgery in the Mount Sinai Health System.

Exclusion Criteria:

* Individuals less than 18 years old, pregnant women, those without capacity to make their own decisions, and prisoners.

Where it's running

• New York Eye and Ear Infirmary of Mount Sinai
  New York, New York, United States Recruiting

Study contacts

• Study coordinator: Gautam Kamthan, MD
• Email: gautam.kamthan@mountsinai.org
• Phone: 212-979-4000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bimatoprost implant with SpyGlass intraocular lens vs timolol drops for cataract patients with glaucoma

  This study tests whether placing a bimatoprost implant together with a SpyGlass intraocular lens during cataract surgery controls eye pressure better than daily timolol drops in people with mild to moderate open‑angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · San Antonio, Texas · NCT07218796

• Combining a bimatoprost eye implant with the SpyGlass intraocular lens versus timolol eye drops for people having cataract removal

  This study will test whether placing a small bimatoprost implant with the SpyGlass intraocular lens at the time of cataract surgery better controls eye pressure than using timolol eye drops in people with mild to moderate open-angle glaucoma or ocular hypertension.

  Recruiting Phase 3 SpyGlass Pharma, Inc. · Houston, Texas · NCT07218783

• My Eyes, My Light — community eye screening in Char Fasson

  This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.

  Recruiting Data Yakka, Inc. · Char Fasson, Bhola · NCT07135570

• Vision screening in general practice to catch preventable sight loss in people over 70

  This project will test a GP-based vision-screening program for people aged 70 and older with at least one chronic condition to find sight problems early.

  Recruiting at 2 sites University of Copenhagen · Copenhagen, Capital Region and 1 other locations · NCT07015034

• Comparing two microinvasive glaucoma surgeries with cataract surgery

  This study tests which of two new glaucoma surgeries, MINIject or Hydrus, works better when done with cataract surgery for people with chronic glaucoma.

  Recruiting Medical University of Graz · Graz, Styria · NCT06844292

• Cataract surgery using low pressure techniques for glaucoma patients

  This study is testing a new cataract surgery method using lower pressure to see if it helps glaucoma patients have safer and better outcomes.

  Recruiting Visionair Oogzorg · Geel · NCT06712758

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.